Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD55 antibody (AA 35-126)

CD55 Reactivity: Human IHC, ELISA, IF Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7148376
  • Target See all CD55 Antibodies
    CD55 (Complement Decay-Accelerating Factor (CD55))
    Binding Specificity
    • 15
    • 9
    • 6
    • 6
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 35-126
    Reactivity
    • 109
    • 33
    • 7
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    Human
    Host
    • 70
    • 65
    • 6
    • 6
    • 3
    • 1
    • 1
    Rabbit
    Clonality
    • 85
    • 65
    • 2
    Polyclonal
    Conjugate
    • 71
    • 17
    • 16
    • 12
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This CD55 antibody is un-conjugated
    Application
    • 96
    • 80
    • 46
    • 36
    • 32
    • 25
    • 16
    • 15
    • 14
    • 13
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human Complement decay-accelerating factor protein (35-126AA)
    Isotype
    IgG
    Top Product
    Discover our top product CD55 Primary Antibody
  • Application Notes
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CD55 (Complement Decay-Accelerating Factor (CD55))
    Alternative Name
    CD55 (CD55 Products)
    Synonyms
    CR antibody, CROM antibody, DAF antibody, TC antibody, Daf antibody, Daf-GPI antibody, Daf1 antibody, GPI-DAF antibody, CD55 molecule (Cromer blood group) antibody, CD55 molecule, decay accelerating factor for complement antibody, CD55 antibody, Cd55 antibody
    Background

    Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.

    Aliases: CD 55 antibody, CD55 antibody, CD55 antigen antibody, CD55 Cromer blood group system antibody, CD55 Molecule (Cromer blood group) antibody, CD55 Molecule antibody, CD55 Molecule, decay accelerating factor for complement (Cromer blood group) antibody, Cd55a antibody, Complement decay accelerating factor antibody, Complement decay-accelerating factor antibody, Complement decay-accelerating factor, GPI-anchored antibody, CR antibody, CROM antibody, Cromer Blood Group antigen antibody, Cromer blood group system antibody, DAF antibody, Daf-GPI antibody, DAF_HUMAN antibody, Daf1 antibody, Dcay accelerating factor for complement (CD55, Cromer blood group system) antibody, Decay accelarating factor 1, isoform CRA_a antibody, Decay accelerating factor (GPI-form) antibody, Decay Accelerating Factor for Complement antibody, Decay accelerating factor GPI-form antibody, Decay accelerating factor soluble-form antibody, GPI-DAF antibody, TC antibody

    UniProt
    P08174
    Pathways
    Complement System, Regulation of Leukocyte Mediated Immunity
You are here:
Support